Although the receptors tend to be tumor suppressive, it has recently been reported that GAL released by HNSCC cells exerted a pro-tumoral and immune-suppressive effect and data from the Cancer Genome Atlas have shown that a reduced overall survival of HNSCC patients was correlated with a high expression of GAL [202]. Here, GAL is linked to cancer.